Publicaciones en colaboración con investigadores/as de Institut Català de la Salut (10)

2022

  1. Association of renin-angiotensin system blockers with COVID-19 diagnosis and prognosis in patients with hypertension: a population-based study

    Clinical Kidney Journal, Vol. 15, Núm. 1, pp. 79-94

  2. Long-Term Variation in Kidney Function and Its Impact After Acute Myocardial Infarction

    American Journal of Cardiology, Vol. 163, pp. 20-24

2020

  1. Impact of implementing a dyslipidemia management guideline on cholesterol control for secondary prevention of ischemic heart disease in primary care

    International Journal of Environmental Research and Public Health, Vol. 17, Núm. 22, pp. 1-15

2017

  1. Clinical Implications of Focal Intimal Disruption in Patients With Type B Intramural Hematoma

    Journal of the American College of Cardiology, Vol. 69, Núm. 1, pp. 28-39

  2. Effectiveness and safety of drugs used for stroke prevention in a cohort of non-valvular atrial fibrillation patients from a primary care electronic database

    Pharmacoepidemiology and Drug Safety, Vol. 26, Núm. 1, pp. 97-107

  3. The use of a binary composite endpoint and sample size requirement: Influence of endpoints overlap

    American Journal of Epidemiology, Vol. 185, Núm. 9, pp. 832-841

2016

  1. Drug Therapy for Rate and Rhythm Control in Nonvalvular Atrial Fibrillation: A Cross-sectional Study with Electronic Health Records in a Primary Care Cohort

    Clinical Therapeutics, Vol. 38, Núm. 4, pp. 863-873

  2. Effectiveness, safety and costs of thromboembolic prevention in patients with non-valvular Atrial fibrillation: Phase I ESC-FA protocol study and baseline characteristics of a cohort from a primary care electronic database

    BMJ Open, Vol. 6, Núm. 1

2005

  1. Validity of composite end points in clinical trials

    British Medical Journal, Vol. 330, Núm. 7491, pp. 594-596

2002

  1. La influencia de los métodos de presentación de los resultados en ensayos clínicos sobre la eficacia de una intervención y la intencón de prescribir fármacos para la prevención cardiovascular

    Revista Espanola de Cardiologia, Vol. 55, Núm. 10, pp. 1042-1051